Danaher shares jump 7% as the turnaround in biotech finally arrives
There was much more to like in this print, including strong headline results on the back of strength in all key operating segments.
Stay updated with breaking news from Sartorius Ag. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
There was much more to like in this print, including strong headline results on the back of strength in all key operating segments.
“Biopharmaceutical Processing Equipment Consumables Market” from 2024-2034 with covered segments (Biopharmaceutical Processing Equipment Consumables...
German pharma and lab supplier Sartorius reported that fiscal 2023 profit to equity holders of Sartorius AG declined to €205.2 million ($220 million) from €678.1 million, last year. Earnings per share reached €2.99 compared to €9.91. Relevant net profit to shareholders of Sartorius fell by 48.3% to €338.5 million euros. Underlying earnings per ordinary share decreased by 48.4% to €4.94 from €9.57. Fiscal year group sales revenue decreased by 16.6% in constant currencies to €3.40 billion in 2023.
Sartorius AG (SARTF), a manufacturer of medical lab equipment, on Friday reported lower earnings and revenue for fiscal 2023, citing soft demand that resulted in weak results across the entire life science sector.
The Investing Club holds its "Morning Meeting" every weekday at 10:20 a.m. ET.